No votes yet

Asthma Today: Implementing the NAEPP EPR-3 Guidelines for the Diagnosis and Management of Asthma in the Primary Care Practice

Course description

Asthma is highly prevalent in the U.S. population and is consistently one of the top five most costly health conditions.  Asthma currently affects 8% of U.S. adults (18.7 million persons) and 9.3% of U.S. children (6.8 million persons). The goals for this one-hour asthma education program for primary care providers are to: 

• Provide instruction on the practical application of the NAEPP* Expert Panel Report-3 2007 Guidelines for the Diagnosis and Management of Asthma

• Demonstrate practical methods for patient education in the primary care practice. 

*National Asthma Education and Prevention Program
Target audience: 

Primary care providers who care for children with asthma.

Learning objectives: 

At the conclusion of this program the learner should be able to:
• Apply the clinical guidelines to assess a patient’s asthma severity and prescribe treatment
• Assess and monitor a patient’s level of asthma control and adjust treatment as needed
• Identify methods to educate patients in asthma self-management
• Implement policies for a team approach in managing asthma in the primary care practice 

Physician Accreditation Statements

This Enduring Material activity, Asthma Today: Implementing the NAEPP EPR-3 Report: 2007 Guidelines for the Diagnosis and Management of Asthma in the Primary Care Practice, has been reviewed and is acceptable for up to 1.00 Prescribed credit(s) by the American Academy of Family Physicians. Term of approval begins 10/31/2014. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1 

Credits & accreditation
  • 1.00 AAFP
  • 1.00 Attendance
Faculty & disclosure

Kemi Alli, MD, FAAP

Chief Medical Officer, Henry J. Austin Health Center, Trenton, NJ

Charles K. Dadzie, MD , MD, FAAP, FCCP
Director Pediatric Pulmonology & Critical Care Medicine, K. Hovnanian Children’s Hospital at Jersey Shore University Medical Center, Neptune, NJ

Patti Lucarelli, RN-BC, MSN, CPNP, APN, PMHS
Jane H. Booker Family Health Center, K. Hovnanian Children’s Hospital Jersey Shore University, Medical Center Neptune, NJ

Dee Mallam, RN, Certified Asthma Educator
Allergy and Immunology, Mercerville, NJ

Puthenmadam Radhakrishnan, MD
Bellevue Pediatrics, Trenton, NJ

Margaret Vasil, LPN
Certified Asthma Educator, Bordentown Township

John Winant, MD, FAAAAI
Allergy and Immunology, Mercerville, NJ

Faculty Disclosures:

Kemi Alli, MD, FAAP; Clatie Campbell; Charles K. Dadzie, MD; Robin D’Oria; Fran Gallagher; Harriett Lazarus; Lisa Jones; Janie Lichtenberger; Patricia A Lucarelli; Puthenmadam Radhakrishnan, MD; Melissa Sentorelli; Margaret Vasil, LPN; Joseph Wiedemer, MD have all indicated that they have nothing to disclose relevant to this educational program.

Dee Mallam, RN has disclosed that she is a consultant with Pharmaxis Pharmaceutical ; Stephen Marcella, MD has disclosed that he is a consultant with Merck & CO., Inc.; Roberto V. Nachajon,MD has disclosed that he is on the Speaker’s Bureau of Teva Pharmaceutical; Arthur J. Torre, MD has disclosed that he is on the Speaker’s Bureau of GlaxoSmithKline; John Winant, Jr., MD has disclosed that he is on the Speaker’s Bureau of Teva Pharmaceutical

Unlabeled Use Disclosure:
There will be no discussion of unlabeled use in this educational program.

Course summary
Available credit: 
  • 1.00 AAFP
  • 1.00 Attendance
Course opens: 
Course expires: 
Please login or register to take this course.